Our vision

The concept was to be active in the research and development of new potent biotech-based products to cover regional markets. Enzymes, molecular biology reagents and PCR kits were the first products and then Meshkat Pharmed used its proprietary set of technologies to endow monoclonal antibodies for blood group typing. The next important step for Meshkat Pharmed was to enter therapeutic recombinant protein and monoclonal anti-bodies area.